[1] |
李嘉慧, 刘建鹏, 潘智林, 等. 精神分裂症患者认知功能损伤的神经生物学基础和电生理表现[J]. 中国医学物理学杂志, 2020, 37(1):115-121.
|
[2] |
SHI X J, FAN F C, LIU H, et al. Traditional Chinese medicine decoction combined with antipsychotic for chronic schizophrenia treatment:a systematic review and meta-analysis[J]. Front Pharmacol, 2020, 11:616088.
DOI
URL
|
[3] |
HOGENAAR J T T, VAN BOKHOVEN H. Schizophrenia:complement cleaning or killing[J]. Genes(Basel), 2021, 12(2):259.
|
[4] |
THILAKAVATHI B, SHENBAGA DEVI S, MALAIAPPAN M, et al. EEG power spectrum analysis for schizophrenia during mental activity[J]. Australas Phys Eng Sci Med, 2019, 42(3):887-897.
DOI
|
[5] |
REFISCH A, KOMATSUZAKI S, UNGELENK M, et al. Analysis of CACNA1C and KCNH2 risk variants on cardiac autonomic function in patients with schizophrenia[J]. Genes(Basel), 2022, 13(11):2132.
|
[6] |
CHEN M, JIANG Q, ZHANG L. CACNA1C gene rs1006737 polymorphism affects cognitive performance in chinese han schizophrenia[J]. Neuropsychiatr Dis Treat, 2022, 18:1697-1704.
DOI
URL
|
[7] |
SCOTTI-MUZZI E, CHILE T, VALLADA H, et al. Association between CACNA1C gene rs100737 polymorphism and glutamatergic neurometabolites in bipolar disorder[J]. Eur Neuropsychopharmacol, 2022, 59:26-35.
DOI
URL
|
[8] |
ZHU X, LI R, KANG G, et al. CACNA1C polymorphism(rs2283291)is associated with schizophrenia in chinese males:a case-control study[J]. Dis Markers, 2019, 2019:8062397.
|
[9] |
GUARDIOLA-RIPOLL M, ALMODÓVAR-PAYÁ C, LUBEIRO A, et al. New insights of the role of the KCNH2 gene in schizophrenia:an fMRI case-control study[J]. Eur Neuropsychopharmacol, 2022, 60:38-47.
DOI
URL
|
[10] |
WANG Y, LIU Z, LU J, et al. Biological evaluation and in silico studies of novel compounds as potent TAAR1 agonists that could be used in schizophrenia treatment[J]. Front Pharmacol, 2023, 14:1161964.
DOI
URL
|
[11] |
LUBEIRO A, FATJÓ-VILAS M, GUARDIOLA M, et al. Analysis of KCNH2 and CACNA1C schizophrenia risk genes on EEG functional network modulation during an auditory odd-ball task[J]. Eur Arch Psychiatry Clin Neurosci, 2022, 270(4):433-442.
DOI
|
[12] |
VANWOERDEN S, STEPP S D. The Diagnostic and Statistical Manual of Mental Disorders,Fifth Edition,alternative model conceptualization of borderline personality disorder:a review of the evidence[J]. Personal Disord, 2022, 13(4):402-406.
DOI
URL
|
[13] |
王献丽, 乌建安, 杜锋. 脑电图和事件相关电位在精神分裂症认知功能评估中的应用[J]. 医学信息, 2019, 32(13):97-99.
|
[14] |
ZHU D, YIN J, LIANG C, et al. CACNA1C(rs1006737)may be a susceptibility gene for schizophrenia:an updated meta-analysis[J]. Brain Behav, 2019, 9(6):e01292.
DOI
URL
|
[15] |
ZHANG Z, WANG Y, ZHANG Q, et al. The effects of CACNA1C gene polymorphism on prefrontal cortex in both schizophrenia patients and healthy controls[J]. Schizophr Res, 2019, 204:193-200.
DOI
URL
|
[16] |
GUARDIOLA-RIPOLL M, ALMODÓVAR-PAYÁ C, LUBEIRO A, et al. A functional neuroimaging association study on the interplay between two schizophrenia genome-wide associated genes(CACNA1C and ZNF804A)[J]. Eur Arch Psychiatry Clin Neurosci, 2022, 272(7):1229-1239.
DOI
|
[17] |
TANAKA Y, HAYASHI K, FUJINO N, et al. Functional analysis of KCNH2 gene mutations of type 2 long QT syndrome in larval zebrafish using microscopy and electrocardiography[J]. Heart Vessels, 2019, 34(1):159-166.
DOI
|
[18] |
陈诚, 王惠玲, 王高华, 等. 抑郁症与精神分裂症患者静息态功能磁共振成像与认知功能的差异[J]. 中华精神科杂志, 2020, 53(5):377-383.
|
[19] |
JANG K I, OH J, JUNG W, et al. Unsuccessful reduction of high-frequency alpha activity during cognitive activation in schizophrenia[J]. Psychiatry Clin Neurosci, 2019, 73(3):132-139.
DOI
URL
|
[20] |
YÜKSEL M, MURPHY M, RIPPE J, et al. Decreased mismatch negativity and elevated frontal-lateral connectivity in first-episode psychosis[J]. J Psychiatr Res, 2021, 144:37-44.
DOI
PMID
|
[21] |
LIU Y P, WU X, XIA X, et al. The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia:an updated meta-analysis[J]. BMC Med Genet, 2020, 21(1):159.
DOI
|
[22] |
MOON A L, BRYDGES N M, WILKINSON L S, et al. Cacna1c hemizygosity results in aberrant fear conditioning to neutral stimuli[J]. Schizophr Bull, 2020, 46(5):1231-1238.
DOI
URL
|
[23] |
LUO N, TIAN L, CALHOUN V D, et al. Brain function,structure and genomic data are linked but show different sensitivity to duration of illness and disease stage in schizophrenia[J]. Neuroimage Clin, 2019, 23:101887.
DOI
URL
|
[24] |
BERDENIS VAN BERLEKOM A, NOTMAN N, SNEEBOER M A, et al. DNA methylation differences in cortical grey and white matter in schizophrenia[J]. Epigenomics, 2021, 13(15):1157-1169.
DOI
PMID
|
[25] |
ABDOLALIZADEH A, OSTADRAHIMI H, MOHAJER B, et al. White matter microstructural properties associated with impaired attention in chronic schizophrenia:a multi-center study[J]. Psychiatry Res Neuroimaging, 2020, 302:111105.
DOI
URL
|
[26] |
MIO C, PASSON N, BALDAN F, et al. CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers[J]. Eur J Med Genet, 2020, 63(4):103843.
DOI
URL
|
[27] |
BAINS S, ZHOU W, DOTZLER S M, et al. Suppression and replacement gene therapy for KCNH2-mediated arrhythmias[J]. Circ Genom Precis Med, 2022, 15(6):e003719.
|
[28] |
REN M, HU Z, CHEN Q, et al. KCNH2-3.1 mediates aberrant complement activation and impaired hippocampal-medial prefrontal circuitry associated with working memory deficits[J]. Mol Psychiatry, 2020, 25(1):206-229.
DOI
|
[29] |
HASHIMOTO R, OHI K, YASUDA Y, et al. The KCNH2 gene is associated with neurocognition and the risk of schizophrenia[J]. World J Biol Psychiatry, 2013, 14(2):114-120.
DOI
URL
|